Sign In
Buy GMDA
$0.0327
+0 (+0%)
At Close: Aug 27, 2024
Data further characterize the mechanism for Gamida Cell's proprietary nicotinamide (NAM) technology's expansion and enhancement of cells Data further characterize the mechanism for Gamida Cell's propr
Gamida Cell to Report Third Quarter 2023 Financial Results
08:00am, Wednesday, 01'st Nov 2023
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its fi
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
04:39pm, Monday, 16'th Oct 2023
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced new early data in 10 patients with CD20 positive non-
Gamida Cell Issues Update on Israel Operations
02:00pm, Monday, 09'th Oct 2023
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today issued an update on its operations in Israel. “We remain prof
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
08:53am, Monday, 09'th Oct 2023
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.
Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa
08:00am, Monday, 02'nd Oct 2023
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Abbey Jenkins, President and Chief Executive Off
Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
08:00am, Thursday, 28'th Sep 2023
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that it will be presenting at the Society for Immunot
First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv)
04:30pm, Wednesday, 27'th Sep 2023
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the first patient has received a stem cell trans
Gamida Cell: The Treacherous Path To Profitability
07:02pm, Monday, 14'th Aug 2023
Gamida Cell's approved therapy, Omisirge, shows faster neutrophil recovery and reduced infections in blood cancer patients compared to standard care. The long-term study of Omisirge includes a diverse
Gamida Cell (GMDA)'s Technical Outlook is Bright After Key Golden Cross
10:57am, Friday, 09'th Jun 2023
Gamida Cell Ltd. (GMDA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support.
Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference
04:30pm, Wednesday, 31'st May 2023
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Michele Korfin, Chief Operating and Chief Commer
Gamida Cell Ltd. (GMDA) Q1 2023 Earnings Call Transcript
08:39pm, Monday, 15'th May 2023
Gamida Cell Ltd. (NASDAQ:GMDA ) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Mike Kuczkowski - Corporate Communications Abbey Jenkins - President and CEO Michele Korfin
Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
05:20pm, Thursday, 11'th May 2023
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will host a conference call and live
Penny Stocks To Buy Now? 3 To Watch In The Stock Market Today
12:47pm, Wednesday, 10'th May 2023
Penny stocks with unusual options activity today The post Penny Stocks To Buy Now? 3 To Watch In The Stock Market Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks
Why Is Gamida Cell (GMDA) Stock Down 19% Today?
09:01am, Wednesday, 19'th Apr 2023
Gamida Cell (NASDAQ: GMDA ) stock is falling on Wednesday after the cell therapy company revealed details of a public securities offering. According to a press release from the company, it is selling
